OCI-AML5人急性髓細(xì)胞性
- 公司名稱(chēng) 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/2/12 8:39:37
- 訪問(wèn)次數(shù) 15
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
OCI-AML5 人急性髓細(xì)胞性白血病細(xì)胞
Catalogue No.: C823
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%IMDM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a 15 ml centrifuge tube | 2X106 |
| Manual | 1 copy |
191560449-01 （同微-信）
signals, such as the immune checkpoint molecules programpkd death-1 and programpkd deathligａnd 1 (PD-L1). This paper also describes past clinical trials of immunotherapy for patients with GC and details their clinical implications. Strong predictive markers are essential to improve response to immunotherapy. Microsatellite instability, Epstein-Barr virus, PD-L1 expression, and
采購(gòu)中心
化工儀器網(wǎng)